Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mutant proteins (compound)
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Most Relevant Literature
- Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of …
- Bioinformatics Insights on the Physicochemical Properties of SCN5A Mutant Proteins Associated with t…
- Identification of mutant p53-specific proteins interaction network using TurboID-based proximity lab…
- Epilepsy-causing Reelin mutations result in impaired secretion and intracellular degradation of muta…
- Structural And Computational Perspectives of Selectively Targeting Mutant Proteins.
Most Relevant Clinical Trials
- A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C…
- Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest S…
- A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Ce…
- Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
